Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.93% | 3.44% | 21.69% | 123.83% | 13.55% |
| Total Depreciation and Amortization | 0.16% | -3.06% | -23.47% | -26.94% | -25.29% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 11.54% | -- | -- |
| Total Other Non-Cash Items | -12.86% | 8.07% | 17.98% | -154.24% | 47.88% |
| Change in Net Operating Assets | 231.86% | -64.18% | -512.54% | -69.89% | -135.32% |
| Cash from Operations | -35.21% | -15.80% | 22.89% | 78.05% | 33.14% |
| Capital Expenditure | -90.32% | -339.77% | -520.73% | -849.74% | -587.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -277.30% | -94.40% | -96.65% | -1,175.59% | 158.62% |
| Cash from Investing | -791.02% | -546.68% | -865.21% | -1,221.66% | 72.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.52% | -89.83% | 53.40% | -37.26% | -4.85% |
| Repurchase of Common Stock | -60.00% | 66.67% | 75.00% | 57.14% | 99.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.47% | -98.34% | 53.68% | -37.21% | 74.84% |
| Foreign Exchange rate Adjustments | -105.77% | 116.98% | 123.29% | -3,650.00% | 260.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.18% | -578.89% | -43.20% | -116.37% | 51.48% |